In recent years, the COVID-19 pandemic, geopolitical conflicts and major logistical failures have led to major disruptions in the supply chain. The biopharmaceutical sector, in particular, has felt the impact of these events most sharply, facing exceptional pressure to fast-track vaccine and therapy development within critical timelines.Progressive enterprises have met...